NUTM1 and nut midline carcinoma: Our patient’s tumor showed only the single BRD4-NUT fusion mutation, negative PD-L1, and a low TMB, typical of NMC.30,31 However, RNA sequencing demonstrated overexpression of multiple potential therapeutic targets.